The relationship between serum adalimumab and corresponding anti-adalimumab antibody levels: analysis of over 20,000 patient results

被引：3

作者：

Kelly, Chun ^{[1
]}

Imir, Metushi ^{[1
]}

Jeanne, Eby ^{[1
]}

Stephen, Phagoo ^{[1
]}

Morgan, Herle ^{[1
]}

James, Iha ^{[1
]}

Jane, Yang ^{[1
]}

机构：

[1] LabCorp, Calabasas, CA USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷

关键词：

D O I：

10.14309/01.ajg.0000578336.45781.9d

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P066

引用

页码：S17 / S18

页数：2

共 50 条

[1] The Relationship Between Serum Infliximab and Adalimumab Concentrations and Their Corresponding Anti-drug Antibody Levels: Analysis of over 50,000 Patient Results
Chun, Kelly Y.
Yang, Jane M.
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S385 - S386
[2] Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
van Kuijk, A. W. R.
de Groot, M.
Stapel, S. O.
Dijkmans, B. A. C.
Wolbink, G. J.
Tak, P. P.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 624 - U187
[3] Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
Bartelds, Geertje M.
Wijbrandts, Carla A.
Nurmohamed, Michael T.
Stapel, Steven
Lems, Willem F.
Aarden, Lucien
Dijkmans, Ben A. C.
Tak, Paul Peter
Wolbink, Gerrit Jan
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) : 921 - 926
[4] Trough levels of adalimumab and the appearances of anti-adalimumab antibody in non-infectious uveitis patients treated with Adalimumab
Suzuki, K.
Iwata, D.
Namba, K.
Mizuuchi, K.
Fukuhara, T.
Ohno, S.
Kitaichi, N.
Ishida, S.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S174 - S174
[5] Early Adalimumab and Anti-Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
Ding, Xiaoliang
Zhu, Ruifang
Wu, Jian
Xue, Ling
Gu, Meihua
Miao, Liyan
[J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (03): : 547 - 554
[6] NO PREDICTIVE VALUE OF ADALIMUMAB SERUM LEVELS AND ANTI-ADALIMUMAB ANTIBODIES AT TIME OF ADALIMUMAB FAILURE FOR PREDICTION OF RESPONSE TO THE NEXT BDMARD
Den Broeder, N.
Ulijn, E.
Wientjes, M.
Van Herwaarden, N.
Meek, I.
Tweehuysen, L.
Van der Maas, A.
Van den Bemt, B.
Den Broeder, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1388 - 1389
[7] ASSOCIATION OF CLINICAL EFFICACY WITH SERUM LEVEL OF ADALIMUMAB (ADA) AND ANTI-ADALIMUMAB ANTIBODY LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)
Avdeeva, A. S.
Aleksandrova, E. N.
Novikov, A. A.
Karateev, D. E.
Luchihina, E. L.
Cherkasova, M. V.
Nasonov, E. L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 927 - 927
[8] Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD
Ulijn, Evy
den Broeder, Nathan
Wientjes, Maike
van Herwaarden, Noortje
Meek, Inger
Tweehuysen, Lieke
van der Maas, Aatke
van den Bemt, Bart J. F.
den Broeder, Alfons A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 867 - 873
[9] Accurate Determination of Serum Adalimumab and Anti-Adalimumab Antibodies Levels During Maintenance Therapy for Crohn's Disease
Imaeda, Hirotsugu
Takahashi, Kenichiro
Fujimoto, Takehide
Bamba, Shigeki
Sasaki, Masaya
Tsujikawa, Tomoyuki
Fujiyama, Yoshihide
Andoh, Akira
[J]. GASTROENTEROLOGY, 2013, 144 (05) : S431 - S431
[10] Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn's disease
Bodini, Giorgia
Giannini, Edoardo G.
Savarino, Vincenzo
Del Nero, Lorenzo
Pellegatta, Gaia
De Maria, Costanza
Baldissarro, Isabella
Savarino, Edoardo
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1081 - 1086

← 1 2 3 4 5 →